Keywords
Chronic Disease
Hypertension
Primary Health Care
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To characterize the epidemiological counter and to estimate gender differences in the relationship between control of NCDs and COVID-19 complications between patients treated at PHC from a countryside city of Bahia. Methods: This is a quantitative, cross-sectional, and analytical study, using medical records of 274 patients with COVID-19 and NCDs, treated at FHU from a municipality in Bahia, between March 11th of 2020 and November 11th of 2021. Patients were classified to gender, age, diagnosis of COVID-19, control, and diagnosis of NCDs. The statistical analysis was through of Stata software. This study was approved by the Research Ethics Comitee. Results: Among patients, 63,5% were women, and 38,5% were men. 274 patients had hypertension; from this, 14,6% also had diabetes. Of the patients, 93,1% of patients were not hospitalized and 2,2% came to death. Uncontrolled blood pressure was higher at the time of COVID-19 diagnosis than in FHU measures. Conclusion: There is most patients with COVID-19 were women. In the both genders, the COVID-19 may have contributed to lack of control of blood pressure. In addition, emphasizes the importance of PHC in the patient’s follow-up.
References
AHMED SB e DUMANSKI SM. Sexo, gênero e COVID-19: um apelo à ação. Canadian Journal of Public Health, 2020; 111(6): 980-983.
BARBOSA KH, et al. O uso do prontuário eletrônico como ferramenta no exercício da Enfermagem: relato de experiência. Brazilian Journal of Health Review, 2020; 3(6): 15803-15811.
BASSI D, et al. Efeitos da Coexistência de Diabetes Tipo 2 e Hipertensão sobre a Variabilidade da Frequência Cardíaca e Capacidade Cardiorrespiratória. Arquivos Brasileiros de Cardiologia, 2018; 111: 64-72.
BRASIL. Ministério da Saúde 2017. Portaria nº 2.436, de 21 de setembro de 2017. Aprova a Política Nacional de Atenção Básica, estabelecendo a revisão de diretrizes para a organização da Atenção Básica, no âmbito do Sistema Único de (SUS). Diário Oficial da União, 2017.
BRASIL. Ministério da Saúde 2020. Secretaria de Vigilância em Saúde. Plano de ações estratégicas para o enfrentamento das doenças crônicas e agravos não transmissíveis no Brasil, 2021-2030.
BRASIL. Ministério da Saúde 2021. Secretaria de Vigilância em Saúde. Boletim epidemiológico especial - Semana Epidemiológica 8, 21 a 27/2/2021.
BRASIL. Ministério da Saúde 2021. Boletim Epidemiológico Especial Doença pelo Coronavírus COVID-19. Semana Epidemiológica, 2021; 8.
REINHARDT ÉL. Transmissão da COVID-19: um breve reexame das vias de transmissão por gotículas e aerossóis. Revista Brasileira de Saúde Ocupacional, 2022; 47.
CLARK A, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet Global Health, 2020; 8(8): e1003-1017.
CHISINI LA, et al. Impact of the COVID-19 pandemic on prenatal, diabetes and medical appointments in the Brazilian National Health System. Revista Brasileira de Epidemiologia, 2021; 24: e210013.
EPIDEMIOLOGIA. 2022. In: COVID-19 Dashboardby the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Disponível em: https://coronavirus.jhu.edu/. Acessado em: 25 de agosto de 2022.
ESAKANDARI H, et al. A comprehensive review of COVID-19 characteristics. Biological Procedures Online, 2020; 22(1): 1-10.
ESTRELA FM, et al. Covid-19 e doenças crônicas: impactos e desdobramentos frente à pandemia. Revista Baiana de Enfermagem, 2020; 34.
FONSECA GSGB, et al. Avaliação do perfil clínico-epidemiológico dos óbitos por COVID-19 em homens e mulheres adultos no estado do Maranhão. E-Acadêmica, 2022; 3(2): e8532255-e8532255.
GEBHARD C, et al. Impact of sex and gender on COVID-19 outcomes in Europe. Biology of sex differences, 2020; 11(1): 1-13.
IOANNIDIS JPA. Global perspective of COVID-19 epidemiology for a full-cycle pandemic. European Journal of Clinical Investigation, 2020; 50(12): e13423.
LIPSA A e PRABHU JS. Gender disparity in COVID-19: Role of sex steroid hormones. Asian Pacific journal of tropical medicine, 2021; 14(1): 5.
MACINKO J e MENDONÇA CS. Estratégia Saúde da Família, um forte modelo de Atenção Primária à Saúde que traz resultados. Saúde em Debate, 2018; 42: 18-37.
MALTA DC, et al. Probability of premature death for chronic non-communicable diseases, Brazil and Regions, projections to 2025. Revista Brasileira de Epidemiologia, 2019; 22: e190030.
MEHANDRU S e MERAD M. Pathological sequelae of long-haul COVID. Nature Immunology, 2022; 23(2): 194-202.
MILLS KT, et al. The global epidemiology of hypertension. Nat Rev Nephrol, 2020; 16(4): 223–37.
MOHAMED MS, et al. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine, 2021; 71(1): 3-8.
REZER F, et al. Taxas de COVID-19 nas mesorregiões do estado de Mato Grosso: casos confirmados e notificados. Rev Pre Infec e Saúde, 2020; 6.
RIBEIRO AC, UEHARA A. Hipertensão arterial sistêmica como fator de risco para a forma grave da covid-19: revisão de escopo. Revista de Saúde Pública, 2022; 56.
RIBEIRO WA, et al. Implementação do prontuário eletrônico do paciente: um estudo bibliográfico das vantagens e desvantagens para o serviço de saúde. Revista Pró-UniverSUS, 2018; 9(1): 07-11.
SANTOS LG, et al. Prevalence of systemic arterial hypertension and diabetes mellitus in individuals with COVID-19: a retrospective study of deaths in Pernambuco, Brazil. Arquivos Brasileiros de Cardiologia, 2021; 117: 416-422.
SHARIFI N e RYAN CJ. Androgen hazards with COVID-19. Endocrine-Related Cancer, 2020; 27(6): e1-e3.
SHI Y, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Critical care, 2020; 24(1): 1-4.
SILVA NJ, et al. Combined association of obesity and other cardiometabolic diseases with severe COVID-19 outcomes: a nationwide cross-sectional study of 21,773 Brazilian adult and elderly inpatients. BMJ aberto, 2021; 11(8): e050739
SINGH K, et al. Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study. BMC Public Health, 2021; 21(1): 1-15.
TRAMUNT B, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia,2020; 63(3): 453-461.
VAN DER KLEIJ RMJJ, et al. SERIES: eHealth in primary care. Part 1: Concepts, conditions and challenges. Taylor & Francis, 2019; 25(4): 179-189.
WANG D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 2020; 323(11): 1061-1069.
WANG Z, et al. Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: a systematic review and meta-analysis without cases. Medicine, 2020; 99(48).
WILDER-SMITH A e FREEDMAN DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. Journal of Travel Medicine, 2020.
XIE Y, et al. Long-term cardiovascular outcomes of COVID-19. Nature, 2022; 28(3): 583-590.